This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Eugene Ponomarev
Introduction
Eugene Ponomarev is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. His innovative approach has led to the development of a unique therapeutic method that utilizes miR-124.
Latest Patents
Eugene Ponomarev holds a patent for the treatment of inflammatory diseases using miR-124. This patent outlines methods for treating, reducing the risk of developing, or delaying the onset of inflammatory diseases. The methods involve providing a subject who is at risk of developing such diseases with an effective amount of a therapeutic composition that includes miR-124. Additionally, the patent includes methods for diagnosing subjects who may be at risk of these conditions.
Career Highlights
Eugene Ponomarev is affiliated with Brigham and Women's Hospital, Inc., where he conducts his research and develops his innovative treatments. His work has garnered attention for its potential to improve patient outcomes in inflammatory disease management.
Collaborations
Eugene has collaborated with esteemed colleagues, including Howard L. Weiner and Tatyana Veremeyko. These partnerships have enhanced the research and development of his therapeutic methods.
Conclusion
Eugene Ponomarev's contributions to the field of medical research, particularly in the treatment of inflammatory diseases, highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for advancements in therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
